About: http://webisa.webdatacommons.org/42351968

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Isis has 19 oligonucleotide-based drugs in development on its own and with partners including Eli Lilly, Bristol-Myers Squibb, Johnson & Johnson, and Genzyme in cardiovascular, metabolic, and neurodegenerative diseases.
http://www.w3.org/ns/prov#wasQuotedFrom	genengnews.com